$CDZI
CADIZ INC Stock $cdzi

$cdzi Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000143774923014364 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$809.0K	$130.0K
YoY Change	337.3%	-8.45%
Cost Of Revenue	$768.0K	$22.00K
YoY Change
Gross Profit	$41.00K	$108.0K
YoY Change	-77.84%
Gross Profit Margin	5.07%	83.08%
Selling, General & Admin	$5.320M	$3.953M
YoY Change	56.24%	3.86%
% of Gross Profit	12975.61%	3660.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$305.0K	$329.0K
YoY Change	77.33%	171.9%
% of Gross Profit	743.9%	304.63%
Operating Expenses	$5.625M	$4.282M
YoY Change	57.25%	9.04%
Operating Profit	-$5.584M	-$4.152M
YoY Change	64.62%	9.7%
Interest Expense	$1.338M	$1.504M
YoY Change	-34.89%	-24.46%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$7.062M	-$10.69M
YoY Change	29.65%	85.06%
Income Tax	$2.000K	$2.000K
% Of Pretax Income
Net Earnings	-$7.064M	-$10.70M
YoY Change	28.83%	80.99%
Net Earnings / Revenue	-873.18%	-8230.77%
Basic Earnings Per Share	-$0.13	-$0.19
Diluted Earnings Per Share	-$0.13	-$0.19
COMMON SHARES
Basic Shares Outstanding	66.60M	66.54M
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$19.24M	$26.28M
YoY Change	45.31%	39.63%
Cash & Equivalents	$19.24M	$26.28M
Short-Term Investments
Other Short-Term Assets	$1.901M	$2.955M
YoY Change	-13.51%	43.59%
Inventory	$1.165M
Prepaid Expenses
Receivables	$880.0K	$225.0K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$23.18M	$29.46M
YoY Change	48.69%	40.26%
LONG-TERM ASSETS
Property, Plant & Equipment	$85.44M	$85.20M
YoY Change	6.12%	7.33%
Goodwill	$5.714M	$5.714M
YoY Change	49.86%	49.86%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.473M	$5.001M
YoY Change	20.6%	9.5%
Total Long-Term Assets	$97.67M	$98.09M
YoY Change	-0.84%	-0.65%
TOTAL ASSETS
Total Short-Term Assets	$23.18M	$29.46M
Total Long-Term Assets	$97.67M	$98.09M
Total Assets	$120.9M	$127.5M
YoY Change	5.92%	6.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.163M	$1.404M
YoY Change	83.73%	28.22%
Accrued Expenses	$1.623M	$1.070M
YoY Change	2.59%	-30.47%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$128.0K	$131.0K
YoY Change	124.56%	59.76%
Total Short-Term Liabilities	$5.768M	$5.429M
YoY Change	60.85%	35.52%
LONG-TERM LIABILITIES
Long-Term Debt	$36.92M	$36.62M
YoY Change	-22.44%	-22.13%
Other Long-Term Liabilities	$38.00K	$37.00K
YoY Change	11.76%	12.12%
Total Long-Term Liabilities	$36.96M	$36.66M
YoY Change	-22.41%	-22.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.768M	$5.429M
Total Long-Term Liabilities	$36.96M	$36.66M
Total Liabilities	$68.22M	$66.73M
YoY Change	-8.84%	-9.99%
SHAREHOLDERS EQUITY
Retained Earnings	-$623.6M	-$615.3M
YoY Change	6.17%	5.97%
Common Stock	$664.0K	$663.0K
YoY Change	31.23%	31.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$52.63M	$60.82M
YoY Change
Total Liabilities & Shareholders Equity	$120.9M	$127.5M
YoY Change	5.92%	6.52%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$7.064M	-$10.70M
YoY Change	28.83%	80.99%
Depreciation, Depletion And Amortization	$305.0K	$329.0K
YoY Change	77.33%	171.9%
Cash From Operating Activities	-$5.802M	-$4.100M
YoY Change	34.06%	28.13%
INVESTING ACTIVITIES
Capital Expenditures	$1.007M	$2.206M
YoY Change	-182.68%	316.23%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$1.007M	-$2.206M
YoY Change	-17.32%	250.16%
FINANCING ACTIVITIES
Cash Dividend Paid		$1.288M
YoY Change		0.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$15.00M
YoY Change		42757.14%
Cash From Financing Activities	-1.306M	$21.27M
YoY Change	0.54%	104.14%
NET CHANGE
Cash From Operating Activities	-5.802M	-$4.100M
Cash From Investing Activities	-1.007M	-$2.206M
Cash From Financing Activities	-1.306M	$21.27M
Net Change In Cash	-8.115M	$14.99M
YoY Change	18.55%	128.33%
FREE CASH FLOW
Cash From Operating Activities	-$5.802M	-$4.100M
Capital Expenditures	$1.007M	$2.206M
Free Cash Flow	-$6.809M	-$6.306M
YoY Change	118.94%	69.06%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Revenues Revenues	130000	usd
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	329
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	329
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	329
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	329
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	70000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	70000000
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	66541262
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	66541262
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	55823810
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	55823810
CY2023Q1	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.08875	pure
CY2023Q1	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	550
CY2022Q1	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.08875	pure
CY2022Q1	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	550
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	66541262
CY2013Q1	cdzi	Number Of Milestones For Common Stock Issuance NumberOfMilestonesForCommonStockIssuance	2	pure
CY2013Q1	cdzi	Shares Payable Term From Date Earned SharesPayableTermFromDateEarned	P3Y
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	us-gaap	Revenues Revenues	142000	usd
CY2023Q1	dei	City Area Code CityAreaCode	213
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	271-1600
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	66595606
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	0-12114
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	77-0313235
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	550 South Hope Street, Suite 2850
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Los Angeles
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90071
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3953000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3806000	usd
CY2023Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	329000	usd
CY2022Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	121000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	4282000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	3927000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4152000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3785000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	1504000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	1991000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	168000	usd
CY2022Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	0	usd
CY2023Q1	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	130000	usd
CY2022Q1	us-gaap	Derivative Gain On Derivative DerivativeGainOnDerivative	0	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5331000	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-10689000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-5776000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
CY2022Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-134000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10691000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-5912000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1265000	usd
CY2022Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	1265000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11956000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7177000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2023Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	62638000
CY2022Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	44433000
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26277000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9997000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	1265000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1288000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	225000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	454000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1690000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	696000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	29457000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	12435000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	85199000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	84138000	usd
CY2023Q1	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	420000	usd
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	420000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	5714000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	5714000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	524000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	553000	usd
CY2023Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1232000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	2497000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5001000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5030000	usd
CY2023Q1	us-gaap	Assets Assets	127547000	usd
CY2022Q4	us-gaap	Assets Assets	110787000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1404000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1107000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1070000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1545000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	131000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	140000	usd
CY2023Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	1265000	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	1288000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1450000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1450000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	109000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	109000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5429000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5639000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	36620000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	48950000	usd
CY2023Q1	cdzi	Lessor Operating Lease Deposit Liabilities LessorOperatingLeaseDepositLiabilities	21251000	usd
CY2022Q4	cdzi	Lessor Operating Lease Deposit Liabilities LessorOperatingLeaseDepositLiabilities	20745000	usd
CY2023Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	2220000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	418000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	444000	usd
CY2023Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	750000	usd
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	750000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	37000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	36000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	66725000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	76564000	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	1000	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	1000	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	663000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	556000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	675411000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	636963000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-615254000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-603298000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	60822000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	34223000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	127547000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	110787000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10691000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-5912000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	329000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	121000	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	194000	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	568000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	29000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	6000	usd
CY2023Q1	cdzi	Paid In Kind Interest Added To Loan Principal PaidInKindInterestAddedToLoanPrincipal	166000	usd
CY2022Q1	cdzi	Paid In Kind Interest Added To Loan Principal PaidInKindInterestAddedToLoanPrincipal	0	usd
CY2023Q1	cdzi	Paid In Kind Interest Added To Lease Liability PaidInKindInterestAddedToLeaseLiability	500000	usd
CY2022Q1	cdzi	Paid In Kind Interest Added To Lease Liability PaidInKindInterestAddedToLeaseLiability	442000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-130000	usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2023Q1	cdzi	Gains Losses On Debt Conversion And Extinguishment Of Debt GainsLossesOnDebtConversionAndExtinguishmentOfDebt	-5331000	usd
CY2022Q1	cdzi	Gains Losses On Debt Conversion And Extinguishment Of Debt GainsLossesOnDebtConversionAndExtinguishmentOfDebt	-0	usd
CY2023Q1	cdzi	Income Loss From Equity Method Investments Excluding Investing Activities IncomeLossFromEquityMethodInvestmentsExcludingInvestingActivities	-0	usd
CY2022Q1	cdzi	Income Loss From Equity Method Investments Excluding Investing Activities IncomeLossFromEquityMethodInvestmentsExcludingInvestingActivities	-134000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	326000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	433000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-229000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-146000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	994000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	102000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-29000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	271000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	523000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	664000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-26000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-246000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	116000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	795000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4069000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3222000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2206000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	530000	usd
CY2023Q1	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	-0	usd
CY2022Q1	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	100000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2206000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-630000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	38490000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	11741000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	1288000	usd
CY2022Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	1288000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	15047000	usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	35000	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	27000	usd
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	-0	usd
CY2023Q1	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	600000	usd
CY2022Q1	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	-0	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	261000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	-0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21267000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10418000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14992000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6566000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13782000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19856000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	28774000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26422000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	34223000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	65000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	38490000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1265000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10691000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	60822000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	40609000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	433000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11741000	usd
CY2022Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1265000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-5912000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	45606000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10700000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-5900000	usd
CY2023Q1	cdzi	Working Capital WorkingCapital	24000000.0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4100000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5300000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	15000000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26277000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9997000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18819000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	1265000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1288000	usd
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	1265000	usd
CY2023Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1232000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	2497000	usd
CY2022Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	6338000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	28774000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13782000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26422000	usd
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2023Q1	us-gaap	Revenues Revenues	130000	usd
CY2023Q1	us-gaap	Revenues Revenues	130000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3953000	usd
CY2023Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	329000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	4282000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4152000	usd
CY2023Q1	us-gaap	Assets Assets	127547000	usd
CY2022Q4	us-gaap	Assets Assets	110787000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	5714000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	5714000	usd
CY2021Q2	cdzi	Water Supply Agreement Number Of Acrefeet Of Water Per Annum To Customer WaterSupplyAgreementNumberOfAcrefeetOfWaterPerAnnumToCustomer	9500	pure
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	326000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	433000	usd
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1819000
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1533000
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1450000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	2350000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	130000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	3670000	usd
CY2023Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	25649000	usd
CY2023Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	25649000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	1450000	usd
CY2023Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	2220000	usd
CY2023Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	3670000	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	70000000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	66541262
CY2013Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	400000
CY2013Q1	cdzi	Percentage Of Projects Annual Capacity PercentageOfProjectsAnnualCapacity	0.51	pure
	us-gaap	Payments Of Dividends PaymentsOfDividends	7843000	usd

Files In Submission

Name	View Source	Status
0001437749-23-014364-index-headers.html	Edgar Link	pending
0001437749-23-014364-index.html	Edgar Link	pending
0001437749-23-014364.txt	Edgar Link	pending
0001437749-23-014364-xbrl.zip	Edgar Link	pending
cdzi-20230331.xsd	Edgar Link	pending
cdzi20230331_10q.htm	Edgar Link	pending
cdzi-20230331_pre.xml	Edgar Link	unprocessable
cdzi-20230331_cal.xml	Edgar Link	unprocessable
cdzi-20230331_def.xml	Edgar Link	unprocessable
cdzi-20230331_lab.xml	Edgar Link	unprocessable
ex_520193.htm	Edgar Link	pending
ex_520194.htm	Edgar Link	pending
ex_520195.htm	Edgar Link	pending
ex_520196.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
cdzi20230331_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CDZI
CADIZ INC Stock $cdzi

2023 Q2 Form 10-Q Financial Statement

#000143774923014364 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDZI CADIZ INC Stock $cdzi

2023 Q2 Form 10-Q Financial Statement

#000143774923014364 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDZI
CADIZ INC Stock $cdzi